FK866 compromises mitochondrial metabolism and adaptive stress responses in cultured cardiomyocytes-Reference-Cited by-同舟云学术

FK866 compromises mitochondrial metabolism and adaptive stress responses in cultured cardiomyocytes

Published:2015-11 Issue:1 Volume:98 Page:92-101
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Oyarzún Alejandra P.,Westermeier Francisco,Pennanen Christian,López-Crisosto Camila,Parra Valentina,Sotomayor-Flores Cristian,Sánchez Gina,Pedrozo Zully,Troncoso Rodrigo,Lavandero Sergio^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference61 articles.

1. Targeting NAMPT for therapeutic intervention in cancer and inflammation: structure-based drug design and biological screening;Pulla;Chem. Biol. Drug Des.,2015

2. Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?;Canto;Pharmacol. Rev.,2012

3. The human NAD metabolome: functions, metabolism and compartmentalization;Nikiforov;Crit. Rev. Biochem. Mol. Biol.,2015

4. Reconstructing eukaryotic NAD metabolism;Rongvaux;Bioessays News Rev. Mol. Cell. Dev. Biol.,2003

5. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial barrier dysregulation;Ye;Microvasc. Res.,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers;Cell Chemical Biology;2024-06

2. Palmatine Attenuated Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting M1 Phenotype Macrophage Polarization via NAMPT/TLR2/CCR1 Signaling;Journal of Agricultural and Food Chemistry;2024-04-15

3. A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome;Blood Advances;2024-04-11

4. Targeting NAD+: is it a common strategy to delay heart aging?;Cell Death Discovery;2022-04-26

5. NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma;Molecular Therapy - Oncolytics;2022-03